Rob Shuter, in a statement with the Daily Mail, describes the “premium-grade, artisanal tension” between Rachel, Joe, and Mika. The outlet says that, according to him, the “friction” between these ...

MS NOW will be launching a direct-to-consumer product that will act as a “home for progressives on digital” following a ratings bump after a recent rebrand. Versant, MS NOW’s parent company, announced ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. Modern living tends to mean spending a lot of time looking at ...

Critics are lambasting MS NOW correspondent Ken Dilanian for seemingly suggesting the suspect who critically injured two National Guardsmen near the White House was reacting to “controversy” ...

The primetime host will debut the new podcast Dec. 1, tackling the series of events that led to the U.S. to incarcerate Japanese Americans at the beginning of World War II. By Alex Weprin Senior ...

Zed was designed from the ground up for machine-native speed and collaboration. Let’s take a look at the newest IDE and text editor on the block. Text editors and IDEs tend to inspire devotion from ...

MSNBC officially rebranded to MS NOW, which stands for My Source for News, Opinion and the World, on Saturday. The name change, which was announced in August, comes as the cable network moves to a new ...

Hey, everyone gets to make a mistake on their first day, right? A self-inflicted technical error hit MS Now on Saturday, just hours into its rebrand from MSNBC, when ...

The cable outlet known until Saturday morning as MSNBC has long been known for newsy hot takes. Now it’s putting some emphasis on reporters’ news breaks. Yes, that was MSNBC in September touting a ...

It was one year ago that Joe Scarborough and his “Morning Joe” co-host and wife Mika Brzezinski were embroiled in what he now dismisses as a “so-called scandal.” The MSNBC duo visited Donald Trump at ...

TL;DR: Get lifetime access to Microsoft Office 2024 Home & Business for Mac or PC for just $169.97 (MSRP $249.99) — Word, Excel, PowerPoint, and Outlook with no ongoing fees. Your career deserves ...

Trial tests drug against relapsing form of the disease Drug candidate as effective as Roche's Ocrevus in a separate study Fenebrutinib could bring in over $1 billion in annual peak sales FRANKFURT, ...